159 related articles for article (PubMed ID: 33508974)
1. Granulomatous uveitis and choroidal detachment in a patient after topical treatment with Bimatoprost: A case report.
Massimo L; Micelli Ferrari L; Nikolopoulou Gisotti E; Zito R; MicelliFerrari T; Anna F; Bordinone MA
Eur J Ophthalmol; 2022 May; 32(3):NP19-NP22. PubMed ID: 33508974
[TBL] [Abstract][Full Text] [Related]
2. [Massive choroidal detachment secondary to topical use of bimatoprost: Report of two cases].
Cheggour M; Gambrelle J
J Fr Ophtalmol; 2012 Mar; 35(3):176-80. PubMed ID: 22281119
[TBL] [Abstract][Full Text] [Related]
3. Flare-up rates with bimatoprost therapy in uveitic glaucoma.
Fortuna E; Cervantes-Castañeda RA; Bhat P; Doctor P; Foster CS
Am J Ophthalmol; 2008 Dec; 146(6):876-82. PubMed ID: 19027422
[TBL] [Abstract][Full Text] [Related]
4. Granulomatous anterior uveitis associated with bimatoprost: a case report.
Parentin F
Ocul Immunol Inflamm; 2003 Mar; 11(1):67-71. PubMed ID: 12854029
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: a preliminary study.
Vyas P; Naik U; Gangaiah JB
Indian J Ophthalmol; 2011; 59(1):13-6. PubMed ID: 21157066
[TBL] [Abstract][Full Text] [Related]
6. Incidence of hyperemia associated with bimatoprost treatment in naïve subjects and in subjects previously treated with latanoprost.
Kurtz S; Mann O
Eur J Ophthalmol; 2009; 19(3):400-3. PubMed ID: 19396785
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
[TBL] [Abstract][Full Text] [Related]
8. Bimatoprost-induced late-onset choroidal detachment after trabeculectomy: A case report and review of the literature.
Nakakura S; Noguchi A; Tabuchi H; Kiuchi Y
Medicine (Baltimore); 2017 Feb; 96(5):e5927. PubMed ID: 28151873
[TBL] [Abstract][Full Text] [Related]
9. Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
Paranhos A; Mendonça M; Silva MJ; Giampani J; Torres RJ; Della Paolera M; Russ H; Lottenberg CL
J Ocul Pharmacol Ther; 2010 Dec; 26(6):611-5. PubMed ID: 21029020
[TBL] [Abstract][Full Text] [Related]
10. A case hypersensitive to bimatoprost and dexamethasone.
Li X; Liu G; Wang Y; Yu W; Xiang H; Liu X
J Ocul Pharmacol Ther; 2011 Oct; 27(5):519-23. PubMed ID: 21936632
[TBL] [Abstract][Full Text] [Related]
11. Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical setting.
Park KH; Simonyi S; Kim CY; Sohn YH; Kook MS
BMC Ophthalmol; 2014 Dec; 14():160. PubMed ID: 25519810
[TBL] [Abstract][Full Text] [Related]
12. Bimatoprost - a review.
Patil AJ; Vajaranant TS; Edward DP
Expert Opin Pharmacother; 2009 Nov; 10(16):2759-68. PubMed ID: 19874254
[TBL] [Abstract][Full Text] [Related]
13. Bilateral nongranulomatous anterior uveitis associated with bimatoprost.
Packer M; Fine IH; Hoffman RS
J Cataract Refract Surg; 2003 Nov; 29(11):2242-3. PubMed ID: 14670442
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of prostaglandin-timolol fixed combinations: a meta-analysis of randomized clinical trials.
Aptel F; Cucherat M; Denis P
Eur J Ophthalmol; 2012; 22(1):5-18. PubMed ID: 22167538
[TBL] [Abstract][Full Text] [Related]
15. A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension.
Trattler W; Noecker RJ; Earl ML
Adv Ther; 2008 Mar; 25(3):179-89. PubMed ID: 18351298
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
[TBL] [Abstract][Full Text] [Related]
17. A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
Coleman AL; Lerner F; Bernstein P; Whitcup SM
Ophthalmology; 2003 Dec; 110(12):2362-8. PubMed ID: 14644719
[TBL] [Abstract][Full Text] [Related]
18. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
Nixon DR
J Ocul Pharmacol Ther; 2013 Dec; 29(10):876-81. PubMed ID: 24070367
[TBL] [Abstract][Full Text] [Related]
19. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
Gandolfi SA; Cimino L
Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
[TBL] [Abstract][Full Text] [Related]
20. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
Parrish RK; Palmberg P; Sheu WP;
Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]